Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
NeurogesX net loss for second-quarter 2010 increases to $10.2 million

NeurogesX net loss for second-quarter 2010 increases to $10.2 million

Summer Academy Meeting highlights benefits of HPV, Herpes Zoster vaccines

Summer Academy Meeting highlights benefits of HPV, Herpes Zoster vaccines

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

Adolor second-quarter net loss decreases to $8.3 million

Adolor second-quarter net loss decreases to $8.3 million

Independent DSMB recommends Inhibitex to complete FV-100 Phase II clinical trial for shingles

Independent DSMB recommends Inhibitex to complete FV-100 Phase II clinical trial for shingles

Winston Laboratories receives NOC for CIVANEX

Winston Laboratories receives NOC for CIVANEX

Frameless radiosurgery can treat most sensitive regions of brain: Study

Frameless radiosurgery can treat most sensitive regions of brain: Study

Endo acquires HealthTronics

Endo acquires HealthTronics

Endo subsidiary successfully completes tender offer for HealthTronics' outstanding common stock

Endo subsidiary successfully completes tender offer for HealthTronics' outstanding common stock

Neuros Medical receives $1.5M Applied Research and Technology Development Award from DMRDP

Neuros Medical receives $1.5M Applied Research and Technology Development Award from DMRDP

Endo responds to FDA Complete Response letter for FORTESTA NDA

Endo responds to FDA Complete Response letter for FORTESTA NDA

FDA's acceptance for filing of DM-1796 NDA triggers $10M milestone payment to Depomed

FDA's acceptance for filing of DM-1796 NDA triggers $10M milestone payment to Depomed

Aestus Therapeutics announces license agreement with Astellas Pharma

Aestus Therapeutics announces license agreement with Astellas Pharma

TheraQuest launches new analgesic product pipeline

TheraQuest launches new analgesic product pipeline

NIH awards Aestus $2M SBIR grant for clinical trials of treatment for chronic neuropathic pain

NIH awards Aestus $2M SBIR grant for clinical trials of treatment for chronic neuropathic pain

Endo, Penwest announce settlement of OPANA ER litigation with Impax

Endo, Penwest announce settlement of OPANA ER litigation with Impax

FDA accepts Depomed's DM-1796 NDA for pain after shingles

FDA accepts Depomed's DM-1796 NDA for pain after shingles

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Mylan subsidiary receives FDA approval for generic version of Neurontin Tablets

Mylan subsidiary receives FDA approval for generic version of Neurontin Tablets